The groundbreaking therapy of this peptide represents a significant breakthrough in the handling of type 2 diabetes. Different to existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide295150.thenerdsblog.com/48146386/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment